Form 4 for TECH Bio-Techne

Accepted 2022-02-03 00:00:00 ET · period of report 2022-02-01 · accession 0001437749-22-002402 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-02-03	2022-02-01	TECH	Geist William	Pres, Protein Sciences	A - Grant	$0.00	+2,490	2,490	New	$0
DM	2022-02-03	2022-02-01	TECH	Geist William	Pres, Protein Sciences	A - Grant	$0.00	+7,802	3,978	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-02-01	A	A	2,490	$0.00	2,490	D	—	—	(F1) Represents 2,490 shares of restricted stock for which the risk of forfeiture will lapse as to 830 shares on each of February 1, 2023, February 1, 2024 and February 1, 2025.
2	Derivative	Restricted Stock Units	2022-02-01	A	A	840	$0.00	840	D	— · — to —	840 Common Stock	(F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F3) Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
3	Derivative	Stock Option (right to buy)	2022-02-01	A	A	2,984	$0.00	2,984	D	$401.57 · — to 2029-02-01	2,984 Common Stock	(F3) Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
4	Derivative	Stock Option (right to buy)	2022-02-01	A	A	3,978	$0.00	3,978	D	$401.57 · — to 2029-02-01	3,978 Common Stock	(F4) Options to purchase 995 shares vest on each of 2/1/2023 and 2/1/2024 and options to purchase 994 shares vest on each of 2/1/2025 and 2/1/2026.